Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Keswani Sanjay Chandru exercised options for 3,212 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Jun 2, 2026 · Filed Jun 4, 2026
On Jun 2, 2026, Keswani Sanjay Chandru (Chief Medical Officer) exercised options for 3,212 Neurocrine Biosciences, Inc. shares, leaving 1,479 shares. Filed Jun 4, 2026 (Form 4).
- Options exercised
- 3,212 shares
- Holding after
- 1,479 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | Option exercise | 3,212 | 3,212 | Direct | |
| Jun 2, 2026 | Common Stock | Shares withheld for tax | 1,733 | US$154.84 | 1,479 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Keswani Sanjay Chandru
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Keswani Sanjay Chandru · Sep 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026